276 related articles for article (PubMed ID: 26764912)
1. Medically Relevant Acinetobacter Species Require a Type II Secretion System and Specific Membrane-Associated Chaperones for the Export of Multiple Substrates and Full Virulence.
Harding CM; Kinsella RL; Palmer LD; Skaar EP; Feldman MF
PLoS Pathog; 2016 Jan; 12(1):e1005391. PubMed ID: 26764912
[TBL] [Abstract][Full Text] [Related]
2. Defining the interaction of the protease CpaA with its type II secretion chaperone CpaB and its contribution to virulence in
Kinsella RL; Lopez J; Palmer LD; Salinas ND; Skaar EP; Tolia NH; Feldman MF
J Biol Chem; 2017 Dec; 292(48):19628-19638. PubMed ID: 28982978
[No Abstract] [Full Text] [Related]
3. InvL, an Invasin-Like Adhesin, Is a Type II Secretion System Substrate Required for Acinetobacter baumannii Uropathogenesis.
Jackson-Litteken CD; Di Venanzio G; Le NH; Scott NE; Djahanschiri B; Distel JS; Pardue EJ; Ebersberger I; Feldman MF
mBio; 2022 Jun; 13(3):e0025822. PubMed ID: 35638734
[TBL] [Abstract][Full Text] [Related]
4. The secretome of Acinetobacter baumannii ATCC 17978 type II secretion system reveals a novel plasmid encoded phospholipase that could be implicated in lung colonization.
Elhosseiny NM; El-Tayeb OM; Yassin AS; Lory S; Attia AS
Int J Med Microbiol; 2016 Dec; 306(8):633-641. PubMed ID: 27713027
[TBL] [Abstract][Full Text] [Related]
5. The structure of
Urusova DV; Kinsella RL; Salinas ND; Haurat MF; Feldman MF; Tolia NH
J Biol Chem; 2019 Sep; 294(36):13344-13354. PubMed ID: 31320476
[TBL] [Abstract][Full Text] [Related]
6. Comparative proteomics analyses of Acinetobacter baumannii strains ATCC 17978 and AB5075 reveal the differential role of type II secretion system secretomes in lung colonization and ciprofloxacin resistance.
Elhosseiny NM; Elhezawy NB; Attia AS
Microb Pathog; 2019 Mar; 128():20-27. PubMed ID: 30578836
[TBL] [Abstract][Full Text] [Related]
7. The Glycoprotease CpaA Secreted by Medically Relevant Acinetobacter Species Targets Multiple
Haurat MF; Scott NE; Di Venanzio G; Lopez J; Pluvinage B; Boraston AB; Ferracane MJ; Feldman MF
mBio; 2020 Oct; 11(5):. PubMed ID: 33024038
[TBL] [Abstract][Full Text] [Related]
8. Targeting the Type II Secretion System: Development, Optimization, and Validation of a High-Throughput Screen for the Identification of Small Molecule Inhibitors.
Waack U; Johnson TL; Chedid K; Xi C; Simmons LA; Mobley HLT; Sandkvist M
Front Cell Infect Microbiol; 2017; 7():380. PubMed ID: 28894700
[TBL] [Abstract][Full Text] [Related]
9. Pathogenic
Harding CM; Pulido MR; Di Venanzio G; Kinsella RL; Webb AI; Scott NE; Pachón J; Feldman MF
J Biol Chem; 2017 Jun; 292(22):9075-9087. PubMed ID: 28373284
[TBL] [Abstract][Full Text] [Related]
10. Acinetobacter baumannii Is Dependent on the Type II Secretion System and Its Substrate LipA for Lipid Utilization and In Vivo Fitness.
Johnson TL; Waack U; Smith S; Mobley H; Sandkvist M
J Bacteriol; 2015 Dec; 198(4):711-9. PubMed ID: 26668261
[TBL] [Abstract][Full Text] [Related]
11. A new means to identify type 3 secreted effectors: functionally interchangeable class IB chaperones recognize a conserved sequence.
Costa SC; Schmitz AM; Jahufar FF; Boyd JD; Cho MY; Glicksman MA; Lesser CF
mBio; 2012; 3(1):. PubMed ID: 22334517
[TBL] [Abstract][Full Text] [Related]
12. The Secrets of Acinetobacter Secretion.
Weber BS; Kinsella RL; Harding CM; Feldman MF
Trends Microbiol; 2017 Jul; 25(7):532-545. PubMed ID: 28216293
[TBL] [Abstract][Full Text] [Related]
13. Direct interactions between the secreted effector and the T2SS components GspL and GspM reveal a new effector-sensing step during type 2 secretion.
Michel-Souzy S; Douzi B; Cadoret F; Raynaud C; Quinton L; Ball G; Voulhoux R
J Biol Chem; 2018 Dec; 293(50):19441-19450. PubMed ID: 30337370
[TBL] [Abstract][Full Text] [Related]
14. Pathogenic Acinetobacter: from the Cell Surface to Infinity and Beyond.
Weber BS; Harding CM; Feldman MF
J Bacteriol; 2015 Dec; 198(6):880-7. PubMed ID: 26712938
[TBL] [Abstract][Full Text] [Related]
15. Unraveling extracellular protein signatures to enhance live attenuated vaccine development through type II secretion system disruption in Vibriomimicus.
Feng Y; Yu Z; Zhao R; Qin Z; Geng Y; Chen D; Huang X; Ouyang P; Zuo Z; Guo H; Deng H; Huang C; Lai W
Microb Pathog; 2023 Aug; 181():106215. PubMed ID: 37380063
[TBL] [Abstract][Full Text] [Related]
16. Architecture, Function, and Substrates of the Type II Secretion System.
Korotkov KV; Sandkvist M
EcoSal Plus; 2019 Feb; 8(2):. PubMed ID: 30767847
[TBL] [Abstract][Full Text] [Related]
17. Structural interactions define assembly adapter function of a type II secretion system pseudopilin.
Escobar CA; Douzi B; Ball G; Barbat B; Alphonse S; Quinton L; Voulhoux R; Forest KT
Structure; 2021 Oct; 29(10):1116-1127.e8. PubMed ID: 34139172
[TBL] [Abstract][Full Text] [Related]
18. In vitro study of virulence potential of Acinetobacter baumannii outer membrane vesicles.
Jha C; Ghosh S; Gautam V; Malhotra P; Ray P
Microb Pathog; 2017 Oct; 111():218-224. PubMed ID: 28870696
[TBL] [Abstract][Full Text] [Related]
19. The role of intrinsic disorder and dynamics in the assembly and function of the type II secretion system.
Gu S; Shevchik VE; Shaw R; Pickersgill RW; Garnett JA
Biochim Biophys Acta Proteins Proteom; 2017 Oct; 1865(10):1255-1266. PubMed ID: 28733198
[TBL] [Abstract][Full Text] [Related]
20. Native and Foreign Proteins Secreted by the
Xu H; Denny TP
J Microbiol Biotechnol; 2017 Apr; 27(4):791-807. PubMed ID: 28119513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
